Use of Anaerofustis stercorihominis in preventing and/or treating metabolic diseases
US11903981B2 · kind B2 · utility
0Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 2018 |
| Grant date | Feb 20, 2024 |
| Priority date | — |
| Expiry date | Feb 15, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Use of Anaerofustis stercorihominis in the prevention and/or treatment of metabolic diseases such as obesity, diabetes, atherosclerosis-related diseases, and cardiovascular diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.